Julian Lindsay

12PUBLICATIONS
20CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Respiratory diseasesMedical infection agents (incl. prions)Nanotoxicology, health and safetyHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Nov 24, 2023
Rituximab for posttransplant lymphoproliferative disorder - therapeutic, preemptive, or prophylactic?

Jan Storek, Julian Lindsay

|Aug 18, 2023
Antimicrobials in patients with hematologic malignancies and recipients of hematopoietic cell transplantation and other cellular therapies.

Frank Tverdek, Zahra Kassamali Escobar, Catherine Liu

|Sep 29, 2022
Subtherapeutic concentrations of posaconazole tablet: determining risk factors and effectiveness of a standardized dose adjustment in hematology inpatients.

Jessica Bui, Rochelle Gellatly, Jad Othman

|May 13, 2022
SUBA-Itraconazole for Primary Antifungal Prophylaxis After Allogeneic Hematopoietic Cell Transplantation.

Julian Lindsay, Jad Othman, Yvonne Kong

|Aug 28, 2021
Dynamics of Epstein-Barr virus on post-transplant lymphoproliferative disorders after antithymocyte globulin-conditioned allogeneic hematopoietic cell transplant.

Julian Lindsay, Jad Othman, Michelle K Yong

|Dec 20, 2020
Cytomegalovirus (CMV) management in allogeneic hematopoietic cell transplantation: Pre-transplant predictors of survival, reactivation, and spontaneous clearance.

Julian Lindsay, Jad Othman, Ian Kerridge

Pageof 2

Frequent Collaborators

5 joint publications

Steven A Pergam

2 joint publications

David C M Kong

2 joint publications

Monica A Slavin

2 joint publications

Catherine Liu